PENRYN SURGERY
SARACEN WAY, PENRYN
HF006
The percentage of patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction, who are currently treated with a beta-blocker licensed for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 22 | 36 | 61.1% | |
| HF 4 | 2011 | 31 | 40 | 77.5% | |
| HF 4 | 2012 | 40 | 55 | 72.7% | |
| HF 4 | 2013 | 44 | 58 | 75.9% | |
| HF004 | 2014 | 41 | 52 | 78.8% | |
| HF004 | 2015 | 65 | 85 | 76.5% | |
| HF004 | 2016 | 50 | 62 | 80.6% | |
| HF004 | 2017 | 48 | 63 | 76.2% | |
| HF004 | 2018 | 76 | 93 | 81.7% | |
| HF004 | 2019 | 124 | 156 | 79.5% | |
| HF004 | 2020 | 127 | 158 | 80.4% | |
| HF006 | 2021 | 141 | 181 | 77.9% | |
| HF006 | 2022 | 137 | 152 | 90.1% | |
| HF006 | 2023 | 150 | 161 | 93.2% |
